Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis

Denosumab, a human monoclonal antibody against RANK ligand, is shown to have strong anti-fracture effects in Japanese osteoporosis patients. However, there have been no data showing actions on Japanese bone architecture. Here we show that denosumab continuously improves several geometrical parameter...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Bone Rep
Egile Nagusiak: Sone, Teruki, Kon, Naohiro, Gaither, Kenneth W., Okubo, Naoki, Osakabe, Taisuke, Nakayama, Yutaka, Fukunaga, Masao, Ito, Masako, Nakamura, Toshitaka
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5701790/
https://ncbi.nlm.nih.gov/pubmed/29188222
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bonr.2017.11.002
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak